Immunotherapy HPV Protein Used in Cervical Cancer Shows Low Response Rate But Overall Improvement of Over 50%

Immunotherapy HPV Protein Used in Cervical Cancer Shows Low Response Rate But Overall Improvement of Over 50%

User Photo
SGO2017

3 years
314 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Don Dizon, MD of Massachusetts General Hospital discusses the use of immunotherapy in cervical cancer treatment. He explains a clinical trial where an HPV protein was used for treatment and although there was a low response rate, there was overall improvement of over 50%. This was recorded at the 2017 Society of Gynecologic Oncology (SGO)s Annual Meeting on Womens Cancer® in National Harbor, MD.
Up Next Autoplay